602 related articles for article (PubMed ID: 32466129)
1. Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics.
Raeeszadeh-Sarmazdeh M; Do LD; Hritz BG
Cells; 2020 May; 9(5):. PubMed ID: 32466129
[TBL] [Abstract][Full Text] [Related]
2. Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects.
Levin M; Udi Y; Solomonov I; Sagi I
Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt A):1927-1939. PubMed ID: 28636874
[TBL] [Abstract][Full Text] [Related]
3. The role of TIMPs in regulation of extracellular matrix proteolysis.
Arpino V; Brock M; Gill SE
Matrix Biol; 2015; 44-46():247-54. PubMed ID: 25805621
[TBL] [Abstract][Full Text] [Related]
4. Matrix Metalloproteinases: How Much Can They Do?
Ågren MS; Auf dem Keller U
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32290531
[TBL] [Abstract][Full Text] [Related]
5. Clinical Implications of Compounds Designed to Inhibit ECM-Modifying Metalloproteinases.
Amar S; Minond D; Fields GB
Proteomics; 2017 Dec; 17(23-24):. PubMed ID: 28613012
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases (MMPs) in health and disease: an overview.
Malemud CJ
Front Biosci; 2006 May; 11():1696-701. PubMed ID: 16368548
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory mechanisms in atherosclerosis: the impact of matrix metalloproteinases.
Siasos G; Tousoulis D; Kioufis S; Oikonomou E; Siasou Z; Limperi M; Papavassiliou AG; Stefanadis C
Curr Top Med Chem; 2012; 12(10):1132-48. PubMed ID: 22519444
[TBL] [Abstract][Full Text] [Related]
8. Novel Matrix Metalloproteinase-9 (MMP-9) Inhibitors in Cancer Treatment.
Rashid ZA; Bardaweel SK
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569509
[TBL] [Abstract][Full Text] [Related]
9. Physiological Properties, Functions, and Trends in the Matrix Metalloproteinase Inhibitors in Inflammation-Mediated Human Diseases.
Kim IS; Yang WS; Kim CH
Curr Med Chem; 2023; 30(18):2075-2112. PubMed ID: 36017851
[TBL] [Abstract][Full Text] [Related]
10. Ovarian tissue remodeling: role of matrix metalloproteinases and their inhibitors.
Smith MF; Ricke WA; Bakke LJ; Dow MP; Smith GW
Mol Cell Endocrinol; 2002 May; 191(1):45-56. PubMed ID: 12044918
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of metalloproteinases in spinal ligament degeneration.
Wang C; Wei Z; Yu T; Zhang L
Connect Tissue Res; 2023 Jul; 64(4):310-322. PubMed ID: 36600486
[TBL] [Abstract][Full Text] [Related]
12. Expression and regulation of metalloproteinases and their inhibitors in intervertebral disc aging and degeneration.
Vo NV; Hartman RA; Yurube T; Jacobs LJ; Sowa GA; Kang JD
Spine J; 2013 Mar; 13(3):331-41. PubMed ID: 23369495
[TBL] [Abstract][Full Text] [Related]
13. Metalloproteinases and metalloproteinase inhibitors in age-related diseases.
Gargiulo S; Gamba P; Poli G; Leonarduzzi G
Curr Pharm Des; 2014; 20(18):2993-3018. PubMed ID: 24079771
[TBL] [Abstract][Full Text] [Related]
14. Age-related Macular Degeneration: Current Knowledge of Zinc Metalloproteinases Involvement.
Liva F; Cuffaro D; Nuti E; Nencetti S; Orlandini E; Vozzi G; Rossello A
Curr Drug Targets; 2019; 20(9):903-918. PubMed ID: 30666909
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinases in neuroinflammation.
Rosenberg GA
Glia; 2002 Sep; 39(3):279-91. PubMed ID: 12203394
[TBL] [Abstract][Full Text] [Related]
16. Molecular and clinical insights of matrix metalloproteinases into cancer spread and potential therapeutic interventions.
Siddhartha R; Garg M
Toxicol Appl Pharmacol; 2021 Sep; 426():115593. PubMed ID: 34038713
[TBL] [Abstract][Full Text] [Related]
17. Biochemical and Biological Attributes of Matrix Metalloproteinases.
Cui N; Hu M; Khalil RA
Prog Mol Biol Transl Sci; 2017; 147():1-73. PubMed ID: 28413025
[TBL] [Abstract][Full Text] [Related]
18. Role of Matrix Metalloproteinases in Degenerative Kidney Disorders.
Narula S; Tandon C; Tandon S
Curr Med Chem; 2018; 25(15):1805-1816. PubMed ID: 29210632
[TBL] [Abstract][Full Text] [Related]
19. Potential clinical applications of matrix metalloproteinase inhibitors and their future prospects.
Li W; Saji S; Sato F; Noda M; Toi M
Int J Biol Markers; 2013 Jun; 28(2):117-30. PubMed ID: 23787494
[TBL] [Abstract][Full Text] [Related]
20. TIMP-3 facilitates binding of target metalloproteinases to the endocytic receptor LRP-1 and promotes scavenging of MMP-1.
Carreca AP; Pravatà VM; Markham M; Bonelli S; Murphy G; Nagase H; Troeberg L; Scilabra SD
Sci Rep; 2020 Jul; 10(1):12067. PubMed ID: 32694578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
